You get your cholesterol checked at your annual physical, and a few days later, you get back your results. If you’ve ever looked down the list of acronyms and felt at a loss of how to make sense of ...

If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...

Cardiac health management is more than just discipline; it is about tracking counts and plotting a risk graph with the right tests ...

Researchers have developed an oral compound that selectively tweaks an important fat-regulating receptor in the liver and gut. In early human testing, it lowered triglycerides and other lipid markers ...

Please provide your email address to receive an email when new articles are posted on . Adding olezarsen to lipid-lowering therapy significantly reduced triglyceride levels at 6 months vs. placebo ...

The FDA approved plozasiran (Redemplo) for the reduction of triglycerides in people with familial chylomicronemia syndrome (FCS), the agency announced. The small interfering RNA (siRNA) therapy, ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet. The phase 3 PALISADE trial showed significant triglyceride reduction with ...

NEW ORLEANS — When added to standard lipid-lowering therapy, olezarsen, a drug approved in 2024 for patients with familial chylomicronemia syndrome, significantly lowered triglycerides and reduced the ...

Researchers from Mass General Brigham have found that olezarsen-a drug designed to lower triglyceride levels-can also decrease the risk of acute pancreatitis, a potential complication in patients with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. People with severe hypertriglyceridemia, defined as ...